A Study of ARQ 171 in Patients With Advanced Solid Tumors
Clinical trial NCT00398840 · TERMINATED
Trial details
- NCT number
- NCT00398840
- Sponsor
- ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2008-09-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.